Chloroquine versus hihydroartemisinin-piperaquine with standard high-dose Primaquine given either for 7 days or 14 days in Plasmodium vivax malaria
<br/><strong>Background: </strong>Primaquine is necessary for the radical cure of Plasmodium vivax malaria, but the optimum duration of treatment and best partner drug are uncertain. A randomized controlled trial was performed to compare the tolerability and radical curative effica...
| المؤلفون الرئيسيون: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| التنسيق: | Journal article |
| منشور في: |
Oxford University Press
2018
|